CoChat

The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease

Open access

The DOI matches its Crossref record, with a small difference in title or year; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder characterized by incompletely reversible airflow obstruction. Bacterial infection of the lower respiratory tract contributes to approximately 50% of COPD exacerbations. Even during periods of stable lung function, the lung harbors a community of bacteria, termed the microbiome. The role of the lung microbiome in the pathogenesis of COPD remains unknown. The COPD lung microbiome, like the healthy lung microbiome, appears to reflect microaspiration of oral microflora. Here we describe the COPD lung microbiome of 22 patients with Moderate or Severe COPD compared to 10 healthy control patients. The composition of the lung microbiomes was determined using 454 pyrosequencing of 16S rDNA found in bronchoalveolar lavage fluid. Sequences were analyzed using mothur, Ribosomal Database Project, Fast UniFrac, and Metastats. Our results showed a significant increase in microbial diversity with the development of COPD. The main phyla in all samples were Actinobacteria, Firmicutes, and Proteobacteria. Principal coordinate analyses demonstrated separation of control and COPD samples, but samples did not cluster based on disease severity. However, samples did cluster based on the use of inhaled corticosteroids and inhaled bronchodilators. Metastats analyses demonstrated an increased abundance of several oral bacteria in COPD samples.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0047305

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Taxonomic Identification at the Phylum Level. All sequences were submitted to RDP Classifier for taxonomic identification with a bootstrap cutoff of 50%. Taxonomic results at the phylum level are displayed for each sample with Control samples at the bottom, Moderate COPD samples in the middle, and Severe COPD samples at the top. The legend is organized from most (top) to least abundant (bottom) phyla.
Figure 1 Taxonomic Identification at the Phylum Level. All sequences were submitted to RDP Classifier for taxonomic identification with a bootstrap cutoff of 50%. Taxonomic results at the phylum level are displayed for each sample with Control samples at the bottom, Moderate COPD samples in the middle, and Severe COPD samples at the top. The legend is organized from most (top) to least abundant (bottom) phyla.CC0 · PubMed Central
Figure 2 Principal Coordinate Analysis Demonstrates Clustering of COPD Samples, Inhaled Corticosteroid Users, and Inhaled Bronchodilator Users. Principal coordinate analysis was performed using mothur and Fast UniFrac, and the results for principal coordinates 1 and 2 are shown. A. Control, Moderate COPD, and Severe COPD. Control samples (red) cluster separately from Moderate COPD (blue) and Severe COPD (yellow) samples. Moderate and Severe COPD samples do not cluster separately. Seven COPD samples that separate the most from the control samples are circled and designated “left lower quadrant” (LLQ) samples for further analysis. B. Smokers and Non-Smokers. Smokers (blue) do not cluster separately from Non-Smokers (red). All of the COPD patients had been non-smokers for at least 6 months prior to bronchoscopy. C. Inhaled Corticosteroid Users and Non-Users. Inhaled corticosteroid users (blue, 14 of 22 COPD patients) are more likely to cluster near the intersection of principal coordinates 1 and 2 than non-users (red). D. Inhaled Bronchodilator Users and Non-Users. Inhaled bronchodilator users (blue, 16 of 22 COPD patients) are more likely to cluster near the intersection of principal coordinates 1 and 2 than non-users (red). All patients who received inhaled corticosteroids also received inhaled bronchodilators.
Figure 2 Principal Coordinate Analysis Demonstrates Clustering of COPD Samples, Inhaled Corticosteroid Users, and Inhaled Bronchodilator Users. Principal coordinate analysis was performed using mothur and Fast UniFrac, and the results for principal coordinates 1 and 2 are shown. A. Control, Moderate COPD, and Severe COPD. Control samples (red) cluster separately from Moderate COPD (blue) and Severe COPD (yellow) samples. Moderate and Severe COPD samples do not cluster separately. Seven COPD samples that separate the most from the control samples are circled and designated “left lower quadrant” (LLQ) samples for further analysis. B. Smokers and Non-Smokers. Smokers (blue) do not cluster separately from Non-Smokers (red). All of the COPD patients had been non-smokers for at least 6 months prior to bronchoscopy. C. Inhaled Corticosteroid Users and Non-Users. Inhaled corticosteroid users (blue, 14 of 22 COPD patients) are more likely to cluster near the intersection of principal coordinates 1 and 2 than non-users (red). D. Inhaled Bronchodilator Users and Non-Users. Inhaled bronchodilator users (blue, 16 of 22 COPD patients) are more likely to cluster near the intersection of principal coordinates 1 and 2 than non-users (red). All patients who received inhaled corticosteroids also received inhaled bronchodilators.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 445

Metadata

Authors
Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C., & Isaacson, R. E.
Affiliations
University of Minnesota (US)
Corresponding author
Isaacson, Richard E.
Venue
PLoS ONE
Published
2012-10-11
Volume
7
Issue
10
Pages
e47305
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2077691383
Cited by
437
References
42
Citations by year
2026: 12 · 2025: 25 · 2024: 29 · 2023: 20 · 2022: 37 · 2021: 50 · 2020: 39 · 2019: 26 · 2018: 38 · 2017: 34 · 2016: 37 · 2015: 28 · 2014: 39 · 2013: 20 · 2012: 2
FWCI
22.96
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • University of Minnesota
  • Forskningsrådet om Hälsa, Arbetsliv och Välfärd
  • National Institutes of Health (n01hr096140-001)
  • University of Illinois at Urbana-Champaign
  • National Heart, Lung, and Blood Institute (N01 HR096140, N010HR-96140)
  • National Institute of Allergy and Infectious Diseases (T32AI55433, T32AI055433)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
lung microbiome, chronic obstructive pulmonary disease, COPD exacerbations, bronchoalveolar lavage fluid, microbial diversity, oral bacteria, inhaled corticosteroids, inhaled bronchodilators, disease severity, actinobacteria, Firmicutes, Proteobacteria
MeSH terms
Adult, Aged, Bronchoalveolar Lavage Fluid, Chronic Disease, Female, Humans, Lung, Male, Middle Aged, RNA, Ribosomal, 16S, Proteobacteria, Pulmonary Disease, Chronic Obstructive, Actinobacteria, Bacteroidetes, Fusobacteria, Metagenome, Acidobacteria

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.